Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

ClinicalTrials.gov ID: NCT04276558

Public ClinicalTrials.gov record NCT04276558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Study identification

NCT ID
NCT04276558
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
RECORDATI GROUP
Industry
Enrollment
108 participants

Conditions and interventions

Interventions

  • Udonitrectag Drug
  • Vehicle Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 12, 2020
Primary completion
Apr 28, 2024
Completion
Apr 28, 2024
Last update posted
May 13, 2025

2020 – 2024

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Nature Coast Clinical Research Crystal River Florida 34429-8722
University of Florida Gainesville Florida 32605
University of Maryland School of Medicine UMSOM Baltimore Maryland 21201
University of Michigan - Kellogg Eye Center Ann Arbor Michigan 48105
Mt. Sinai New York Eye and Ear Infirmary New York New York 10003
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Toyos Clinic Nashville Tennessee 37215
Houston Eye Associates HEA - Gramercy Location Houston Texas 77025
University of Wisconsin-Madison Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04276558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04276558 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →